Johnson & Johnson received Food and Drug Administration approval for its Varipulse pulsed field ablation system, joining Medtronic and Boston Scientific as medtech firms with PFA devices on the U.S.
First regulatory approval for the first-of-its-kind, fully-integrated PFA system with a simple and reproducible workflow Integrated with the world's leading CARTO™ 3D cardiac mapping system for the ...
The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ 3 Electro-anatomical Mapping System, driving efficiency, reproducibility ...
The Varipulse platform includes a single-device workflow with minimal to zero fluoroscopy requirements, real-time imaging, and lesion tagging for paroxysmal atrial fibrillation. The FDA has approved ...
HAYWARD, Calif., April 23, 2025--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) ...
Alright. Good morning, everyone. My name is Danielle Antalffy, the med-tech analyst here at UBS. And we are very lucky to have with us on this very exciting fireside chat the Johnson & Johnson ...
Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow. Integrated with the world's leading CARTO™ 3D Cardiac Mapping System for the ...
IRVINE, Calif., Jan. 9, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, i today announced approval from the Japanese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results